These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 10983629

  • 21. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE.
    Cancer Res; 2000 Jun 01; 60(11):2898-905. PubMed ID: 10850435
    [Abstract] [Full Text] [Related]

  • 22. Increased angiogenic growth factor in cyanotic congenital heart disease.
    Himeno W, Akagi T, Furui J, Maeno Y, Ishii M, Kosai K, Murohara T, Kato H.
    Pediatr Cardiol; 2003 Jun 01; 24(2):127-32. PubMed ID: 12360391
    [Abstract] [Full Text] [Related]

  • 23. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels.
    Ameglio F, D'Auria L, Cordiali-Fei P, Mussi A, Valenzano L, D'Agosto G, Ferraro C, Bonifati C, Giacalone B.
    J Biol Regul Homeost Agents; 1997 Jun 01; 11(4):148-53. PubMed ID: 9582615
    [Abstract] [Full Text] [Related]

  • 24. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H.
    Anticancer Res; 2002 Jun 01; 22(5):2957-63. PubMed ID: 12530025
    [Abstract] [Full Text] [Related]

  • 25. Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
    Paisley AN, O'Callaghan CJ, Lewandowski KC, Parkinson C, Roberts ME, Drake WM, Monson JP, Trainer PJ, Randeva HS.
    J Clin Endocrinol Metab; 2006 Nov 01; 91(11):4635-40. PubMed ID: 16926249
    [Abstract] [Full Text] [Related]

  • 26. Factors affecting the outcome of surgical treatment of acromegaly.
    Er LK, Chang TC, Lin SM, Huang KM, Chang CC.
    J Formos Med Assoc; 2000 Mar 01; 99(3):191-8. PubMed ID: 10820950
    [Abstract] [Full Text] [Related]

  • 27. The effects of growth hormone status on circulating levels of vascular growth factors.
    Silha JV, Krsek M, Hana V, Marek J, Weiss V, Jezkova J, Rosicka M, Jarkovska Z, Murphy LJ.
    Clin Endocrinol (Oxf); 2005 Jul 01; 63(1):79-86. PubMed ID: 15963066
    [Abstract] [Full Text] [Related]

  • 28. Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy.
    Freda PU, Reyes-Vidal C, Jin Z, Pugh M, Panigrahi SK, Bruce JN, Wardlaw SL.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5453-5461. PubMed ID: 31361303
    [Abstract] [Full Text] [Related]

  • 29. The imbalance of cathepsin B-like activity in acromegalic patients--preliminary report.
    Daroszewski J, Bolanowski M, Kaluzny M, Siewinski M.
    Neuro Endocrinol Lett; 2010 Nov 01; 31(2):256-60. PubMed ID: 20424577
    [Abstract] [Full Text] [Related]

  • 30. Gender dependence of serum soluble Klotho in acromegaly.
    Sze L, Neidert MC, Bernays RL, Zwimpfer C, Wiesli P, Haile SR, Brändle M, Schmid C.
    Clin Endocrinol (Oxf); 2014 Jun 01; 80(6):869-73. PubMed ID: 24330426
    [Abstract] [Full Text] [Related]

  • 31. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome.
    Thickett DR, Armstrong L, Christie SJ, Millar AB.
    Am J Respir Crit Care Med; 2001 Nov 01; 164(9):1601-5. PubMed ID: 11719296
    [Abstract] [Full Text] [Related]

  • 32. Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly.
    Bayram F, Bitgen N, Donmez-Altuntas H, Cakir I, Hamurcu Z, Sahin F, Simsek Y, Baskol G.
    Growth Horm IGF Res; 2014 Feb 01; 24(1):29-34. PubMed ID: 24382376
    [Abstract] [Full Text] [Related]

  • 33. Micronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegaly.
    Hamurcu Z, Cakir I, Donmez-Altuntas H, Bitgen N, Karaca Z, Elbuken G, Bayram F.
    Metabolism; 2011 Nov 01; 60(11):1620-6. PubMed ID: 21550080
    [Abstract] [Full Text] [Related]

  • 34. The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery.
    Wu TE, Lin HD, Lu RA, Wang ML, Chen RL, Chen HS.
    Growth Horm IGF Res; 2010 Dec 01; 20(6):411-5. PubMed ID: 20943425
    [Abstract] [Full Text] [Related]

  • 35. Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Navarro C, Candia-Zúñiga L, Silveira LH, Ruiz V, Gaxiola M, Avila MC, Amigo MC.
    Lupus; 2002 Dec 01; 11(1):21-4. PubMed ID: 11898914
    [Abstract] [Full Text] [Related]

  • 36. Elevated levels of serum vascular endothelial growth factor in patients with polycythaemia vera.
    Theodoridou S, Vyzantiadis T, Vakalopoulou S, Perifanis V, Tziomalos K, Vyzantiadis A, Garipidou V.
    Acta Haematol; 2003 Dec 01; 110(1):16-9. PubMed ID: 12975551
    [Abstract] [Full Text] [Related]

  • 37. Cancers associated with acromegaly.
    Jenkins PJ.
    Neuroendocrinology; 2006 Dec 01; 83(3-4):218-23. PubMed ID: 17047386
    [Abstract] [Full Text] [Related]

  • 38. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF).
    Dunst J, Becker A, Lautenschläger C, Markau S, Becker H, Fischer K, Haensgen G.
    Strahlenther Onkol; 2002 Aug 01; 178(8):436-41. PubMed ID: 12240549
    [Abstract] [Full Text] [Related]

  • 39. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.
    Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E.
    J Vasc Res; 2000 Aug 01; 37(6):443-8. PubMed ID: 11146397
    [Abstract] [Full Text] [Related]

  • 40. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
    Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY.
    Ophthalmology; 2001 Apr 01; 108(4):705-10. PubMed ID: 11297487
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.